In last trading session, Cassava Sciences Inc (NASDAQ:SAVA) saw 1.83 million shares changing hands with its beta currently measuring -0.41. Company’s recent per share price level of $26.11 trading at $1.6 or 6.53% at ring of the bell on the day assigns it a market valuation of $1.13B. That closing price of SAVA’s stock is at a discount of -22.94% from its 52-week high price of $32.10 and is indicating a premium of 52.82% from its 52-week low price of $12.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 684.47K if we extend that period to 3-months.
Cassava Sciences Inc (NASDAQ:SAVA) trade information
Upright in the green during last session for gaining 6.53%, in the last five days SAVA remained trading in the green while hitting it’s week-highest on Thursday, 04/11/24 when the stock touched $26.11 price level, adding 2.14% to its value on the day. Cassava Sciences Inc’s shares saw a change of 15.99% in year-to-date performance and have moved 27.49% in past 5-day. Cassava Sciences Inc (NASDAQ:SAVA) showed a performance of 25.47% in past 30-days. Number of shares sold short was 11.79 million shares which calculate 16.67 days to cover the short interests.
Cassava Sciences Inc (SAVA) estimates and forecasts
Statistics highlight that Cassava Sciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 34.94% of value to its shares in past 6 months, showing an annual growth rate of 13.36% while that of industry is 9.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 20.70% in the current quarter and calculating 28.60% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -30.45% during past 5 years.
SAVA Dividends
Cassava Sciences Inc is more likely to be releasing its next quarterly report between April 29 and May 03 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Cassava Sciences Inc (NASDAQ:SAVA)’s Major holders
Insiders are in possession of 7.17% of company’s total shares while institution are holding 32.71 percent of that, with stock having share float percentage of 35.24%. Investors also watch the number of corporate investors in a company very closely, which is 32.71% institutions for Cassava Sciences Inc that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at SAVA for having 2.75 million shares of worth $67.35 million. And as of Jun 29, 2023, it was holding 6.54% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group Inc, which was holding about 2.25 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 5.36% of outstanding shares, having a total worth of $55.16 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 1.23 million shares of worth $30.21 million or 2.94% of the total outstanding shares. The later fund manager was in possession of 0.91 million shares on Aug 30, 2023, making its stake of worth around $19.05 million in the company or a holder of 2.16% of company’s stock.
